Brown Advisory Securities Lifted Stake in Merck & Co (MRK) as Shares Rose; Sfe Investment Counsel Holding in First Rep Bk San Francisco C (FRC) Lifted by $779,516 as Stock Value Rose

June 18, 2018 - By Louis Casey

Merck & Co., Inc. (NYSE:MRK) Logo

Brown Advisory Securities Llc increased its stake in Merck & Co Inc (MRK) by 6.87% based on its latest 2018Q1 regulatory filing with the SEC. Brown Advisory Securities Llc bought 6,341 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 98,665 shares of the health care company at the end of 2018Q1, valued at $5.37 million, up from 92,324 at the end of the previous reported quarter. Brown Advisory Securities Llc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $164.04 billion market cap company. The stock decreased 1.70% or $1.055 during the last trading session, reaching $60.975. About 5.43M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 18, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 16/04/2018 – #AACR18 first-line NSCLC I/O showdown in NEJM $MRK Keynote-189; 30/03/2018 – FDA: New Drug Application (NDA): 019555 Company: MERCK SHARP DOHME; 03/04/2018 – ASTRAZENECA, MERCK & CO.: EMA VALIDATED LYNPARZA MAA FOR REVIEW; 17/05/2018 – MERCK INDONESIA TO SELL CONSUMER HEALTH TO PROCTER & GAMBLE; 23/05/2018 – MERCK & CO INC – KEYTRUDA HAS NOW DEMONSTRATED AN IMPROVED SURVIVAL BENEFIT IN ADVANCED NSCLC IN FIVE PHASE 3 TRIALS; 16/04/2018 – Merck Expands Lead in Lung Cancer Therapy (Video); 17/05/2018 – AstraZeneca Granted FDA Orphan Drug Status for Olaparib; 01/05/2018 – Merck Boosts Outlook as Keytruda Sales Surpass Diabetes Drugs; 16/05/2018 – TURNSTONE BIOLOGICS – ENTERED INTO A CLINICAL SUPPLY AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD UNDER WHICH ROCHE WILL PROVIDE ATEZOLIZUMAB (TECENTRIQ); 09/04/2018 – KEYTRUDA® (pembrolizumab) Monotherapy Met Primary Endpoint in Phase 3 KEYNOTE-042 Study, Significantly Improving OS as First-Line Therapy in Locally Advanced or Metastatic NSCLC Patients Expressing PD-L1 in at Least 1 Percent of Tumor…

Sfe Investment Counsel increased its stake in First Rep Bk San Francisco C (FRC) by 25.07% based on its latest 2018Q1 regulatory filing with the SEC. Sfe Investment Counsel bought 8,473 shares as the company’s stock rose 4.55% while stock markets declined. The institutional investor held 42,268 shares of the company at the end of 2018Q1, valued at $3.91M, up from 33,795 at the end of the previous reported quarter. Sfe Investment Counsel who had been investing in First Rep Bk San Francisco C for a number of months, seems to be bullish on the $16.18B market cap company. The stock increased 0.32% or $0.32 during the last trading session, reaching $99.91. About 320,321 shares traded. First Republic Bank (NYSE:FRC) has risen 7.17% since June 18, 2017 and is uptrending. It has underperformed by 5.40% the S&P500. Some Historical FRC News: 24/05/2018 – First Republic Short-Interest Ratio Rises 11% to 13 Days; 13/04/2018 – FIRST REPUBLIC 1Q EPS $1.13; 06/03/2018 – First Republic Volume Rises More Than Triple 20 Day Average; 30/05/2018 – Moody’s assigns provisional ratings to Prime RMBS issued by Sequoia Mortgage Trust 2018-6; 05/03/2018 – Trump’s Lawyer Complained About Not Being Reimbursed for Paying Porn Star; 18/04/2018 – Moody’s assigns provisional ratings to Prime RMBS issued by Sequoia Mortgage Trust 2018-5; 22/03/2018 – FIRST REPUBLIC BANK FRC.N : UBS STARTS WITH NEUTRAL RATING: TARGET PRICE $100; 12/04/2018 – First Republic Bank Chmn and CEO Jim Herbert Appointed to Federal Reserve System’s Federal Advisory Council

Sfe Investment Counsel, which manages about $321.20 million and $192.81 million US Long portfolio, decreased its stake in Computer Programs & Sys Inc (NASDAQ:CPSI) by 22,204 shares to 15,285 shares, valued at $446,000 in 2018Q1, according to the filing. It also reduced its holding in Patterson Companies Inc (NASDAQ:PDCO) by 13,975 shares in the quarter, leaving it with 19,150 shares, and cut its stake in Deluxe Corp (NYSE:DLX).

Among 20 analysts covering First Republic Bank (NYSE:FRC), 9 have Buy rating, 0 Sell and 11 Hold. Therefore 45% are positive. First Republic Bank had 88 analyst reports since October 6, 2015 according to SRatingsIntel. The stock of First Republic Bank (NYSE:FRC) earned “Market Perform” rating by BMO Capital Markets on Monday, October 16. The stock of First Republic Bank (NYSE:FRC) has “Outperform” rating given on Wednesday, November 11 by Raymond James. The firm has “Buy” rating given on Friday, October 13 by Maxim Group. FBR Capital maintained it with “Mkt Perform” rating and $80 target in Friday, October 14 report. The stock has “Buy” rating by Jefferies on Monday, February 22. Maxim Group maintained First Republic Bank (NYSE:FRC) rating on Monday, December 19. Maxim Group has “Buy” rating and $100 target. The firm has “Buy” rating given on Thursday, January 4 by Maxim Group. The company was maintained on Thursday, March 29 by Sandler O’Neill. On Friday, September 1 the stock rating was maintained by Piper Jaffray with “Hold”. The firm earned “Outperform” rating on Monday, October 16 by Raymond James.

More notable recent First Republic Bank (NYSE:FRC) news were published by: Seekingalpha.com which released: “First Republic reports pricing of $300M preferred stock offering” on June 05, 2018, also Seekingalpha.com with their article: “First Republic Bank: This 5.50% Preferred Stock Has Begun Trading On The NYSE” published on June 13, 2018, Streetinsider.com published: “Citi Starts First Republic Bank (FRC) at Buy” on June 18, 2018. More interesting news about First Republic Bank (NYSE:FRC) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For June 18, 2018” published on June 18, 2018 as well as Globenewswire.com‘s news article titled: “Report: Developing Opportunities within Cimarex Energy, MSCI, Prestige Brand, MGM Resorts International, Discover …” with publication date: June 12, 2018.

Brown Advisory Securities Llc, which manages about $869.60M and $537.56 million US Long portfolio, decreased its stake in Vanguard Index Fds (VOE) by 3,214 shares to 1,907 shares, valued at $208,000 in 2018Q1, according to the filing. It also reduced its holding in Rydex Etf Trust (RSP) by 4,857 shares in the quarter, leaving it with 76,623 shares, and cut its stake in Ishares Tr (EEM).

Investors sentiment increased to 1 in 2018 Q1. Its up 0.06, from 0.94 in 2017Q4. It increased, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. Old Natl Comml Bank In, a Indiana-based fund reported 89,216 shares. First Republic Inv Mgmt owns 1.03 million shares. North American Mngmt Corp accumulated 152,490 shares. Colony Grp Ltd Liability Corp reported 27,382 shares stake. Tradition Capital Management Limited Liability Company, New Jersey-based fund reported 135,294 shares. Marathon Asset Management Llp holds 2.69 million shares or 2.28% of its portfolio. State Of New Jersey Common Pension Fund D invested in 0.84% or 4.02M shares. Cubic Asset Lc holds 0.24% in Merck & Co., Inc. (NYSE:MRK) or 15,812 shares. Uss Management Limited holds 774,350 shares or 0.51% of its portfolio. 69,212 are held by Sky Group Inc Ltd Liability. Stonebridge Cap Mngmt invested in 70,153 shares or 1.47% of the stock. Stralem & Co has 3.02% invested in Merck & Co., Inc. (NYSE:MRK). Td Mngmt Ltd Llc accumulated 0.03% or 2,057 shares. Seatown Pte Ltd holds 170,000 shares. Moreover, Kentucky Retirement Insurance Fund has 0.66% invested in Merck & Co., Inc. (NYSE:MRK).

Another recent and important Merck & Co., Inc. (NYSE:MRK) news was published by Seekingalpha.com which published an article titled: “Avoiding The ‘Black Hole’ Of Disease Development” on June 15, 2018.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>